Cargando…
Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis
BACKGROUND: Klotho (KL) was originally characterized as an aging suppressor gene, and has been identified as a tumor suppressor gene in a variety of cancers, including colorectal cancer. Recent years have witnessed the importance of metabolism transformation in cancer cell malignancies maintenance....
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994118/ https://www.ncbi.nlm.nih.gov/pubmed/29884183 http://dx.doi.org/10.1186/s12964-018-0241-2 |
_version_ | 1783330362721566720 |
---|---|
author | Li, Qingguo Li, Yaqi Liang, Lei Li, Jing Luo, Dakui Liu, Qi Cai, Sanjun Li, Xinxiang |
author_facet | Li, Qingguo Li, Yaqi Liang, Lei Li, Jing Luo, Dakui Liu, Qi Cai, Sanjun Li, Xinxiang |
author_sort | Li, Qingguo |
collection | PubMed |
description | BACKGROUND: Klotho (KL) was originally characterized as an aging suppressor gene, and has been identified as a tumor suppressor gene in a variety of cancers, including colorectal cancer. Recent years have witnessed the importance of metabolism transformation in cancer cell malignancies maintenance. Aberrant cancer cell metabolism is considered to be the hallmark of cancer. Our previous studies demonstrated that KL played negative roles in colon cancer cell proliferation and metastasis. However, its role in the cancer cell reprogramming has seldom been reported. The aim of this study was to examine the role of KL in aerobic glycolysis in colorectal cancer. METHODS: Combining maximum standardized uptake value (SUVmax), which was obtained preoperatively via a PET/CT scan, with immunohistochemistry staining, we analyzed the correlation between SUVmax and KL expression in colorectal cancer tissues. The impact of KL on glucose metabolism and its mechanisms were further validated in vitro and in vivo. RESULTS: Patients with lower KL expression exhibited higher (18)F-FDG uptake (P < 0.05), indicating that KL might participate in aerobic glycolysis regulation. In vitro assay by using colon cancer cell lines further supported this observation. By overexpressing KL in HTC116 and SW480 cells, we observed that the glycolysis was inhibited and the mitochondrial respiration increased, indicating that KL was a negative regulator of aerobic glycolysis. To seek for the underlying mechanisms, we tried to dig out the relation between KL and HIF1α signaling pathway, and found that KL negatively regulated HIF1α protein level and transcriptional activity. Western blot analysis showed that KL overexpression negatively regulated ERK pathway, and KL regulated aerobic glycolysis in part through its regulation of ERK/ HIF1α axis. CONCLUSIONS: Taken together, KL is a negative regulator of aerobic glycolysis and KL inhibited glucose metabolism transformation via the ERK/ HIF1α axis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12964-018-0241-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5994118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-59941182018-06-21 Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis Li, Qingguo Li, Yaqi Liang, Lei Li, Jing Luo, Dakui Liu, Qi Cai, Sanjun Li, Xinxiang Cell Commun Signal Research BACKGROUND: Klotho (KL) was originally characterized as an aging suppressor gene, and has been identified as a tumor suppressor gene in a variety of cancers, including colorectal cancer. Recent years have witnessed the importance of metabolism transformation in cancer cell malignancies maintenance. Aberrant cancer cell metabolism is considered to be the hallmark of cancer. Our previous studies demonstrated that KL played negative roles in colon cancer cell proliferation and metastasis. However, its role in the cancer cell reprogramming has seldom been reported. The aim of this study was to examine the role of KL in aerobic glycolysis in colorectal cancer. METHODS: Combining maximum standardized uptake value (SUVmax), which was obtained preoperatively via a PET/CT scan, with immunohistochemistry staining, we analyzed the correlation between SUVmax and KL expression in colorectal cancer tissues. The impact of KL on glucose metabolism and its mechanisms were further validated in vitro and in vivo. RESULTS: Patients with lower KL expression exhibited higher (18)F-FDG uptake (P < 0.05), indicating that KL might participate in aerobic glycolysis regulation. In vitro assay by using colon cancer cell lines further supported this observation. By overexpressing KL in HTC116 and SW480 cells, we observed that the glycolysis was inhibited and the mitochondrial respiration increased, indicating that KL was a negative regulator of aerobic glycolysis. To seek for the underlying mechanisms, we tried to dig out the relation between KL and HIF1α signaling pathway, and found that KL negatively regulated HIF1α protein level and transcriptional activity. Western blot analysis showed that KL overexpression negatively regulated ERK pathway, and KL regulated aerobic glycolysis in part through its regulation of ERK/ HIF1α axis. CONCLUSIONS: Taken together, KL is a negative regulator of aerobic glycolysis and KL inhibited glucose metabolism transformation via the ERK/ HIF1α axis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12964-018-0241-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-06-08 /pmc/articles/PMC5994118/ /pubmed/29884183 http://dx.doi.org/10.1186/s12964-018-0241-2 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Li, Qingguo Li, Yaqi Liang, Lei Li, Jing Luo, Dakui Liu, Qi Cai, Sanjun Li, Xinxiang Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis |
title | Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis |
title_full | Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis |
title_fullStr | Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis |
title_full_unstemmed | Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis |
title_short | Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis |
title_sort | klotho negatively regulated aerobic glycolysis in colorectal cancer via erk/hif1α axis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994118/ https://www.ncbi.nlm.nih.gov/pubmed/29884183 http://dx.doi.org/10.1186/s12964-018-0241-2 |
work_keys_str_mv | AT liqingguo klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis AT liyaqi klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis AT lianglei klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis AT lijing klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis AT luodakui klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis AT liuqi klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis AT caisanjun klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis AT lixinxiang klothonegativelyregulatedaerobicglycolysisincolorectalcancerviaerkhif1aaxis |